Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 263 results

Early research (Phase 1)Study completedNCT02221258
What this trial is testing

Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 9
Not applicableStudy completedNCT05323591
What this trial is testing

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 155
Large-scale testing (Phase 3)Study completedNCT02057250
What this trial is testing

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Who this might be right for
RA
Sanofi 217
Testing effectiveness (Phase 2)Study completedNCT03823391
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 48
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Large-scale testing (Phase 3)Study completedNCT03086343
What this trial is testing

Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 657
Large-scale testing (Phase 3)Study completedNCT06048224
What this trial is testing

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Zhejiang Hisun Pharmaceutical Co. Ltd. 669
Post-approval studies (Phase 4)Study completedNCT01961271
What this trial is testing

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Who this might be right for
OsteoarthritisRheumatoid ArthritisLower Back Pain+2 more
Mundipharma Pte Ltd. 114
Testing effectiveness (Phase 2)Temporarily pausedNCT00777816
What this trial is testing

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
XOMA (US) LLC 18
Not applicableStudy completedNCT01670045
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 43
Large-scale testing (Phase 3)Study completedNCT03155347
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 340
Testing effectiveness (Phase 2)Study completedNCT00205478
What this trial is testing

Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 300
Testing effectiveness (Phase 2)Study completedNCT05957107
What this trial is testing

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Beijing VDJBio Co., LTD. 181
Testing effectiveness (Phase 2)Study completedNCT02065700
What this trial is testing

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 739
Not applicableActive Not RecruitingNCT04871919
What this trial is testing

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 1,304
Testing effectiveness (Phase 2)Looking for participantsNCT07423533
What this trial is testing

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Who this might be right for
Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 450
Large-scale testing (Phase 3)Study completedNCT04171414
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 62
Early research (Phase 1)Looking for participantsNCT06946641
What this trial is testing

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06741969
What this trial is testing

Nipocalimab in Moderate to Severe Sjogren's Disease

Who this might be right for
Sjogrens Syndrome
Janssen Research & Development, LLC 655
Next Page